Home Auxilium Licenses Vivus ED Drug in $300M Deal
 

Keywords :   


Auxilium Licenses Vivus ED Drug in $300M Deal

2013-10-12 03:51:34| Biotech - Topix.net

Auxilium Pharmaceuticals will get the right to sell Vivus' impotence drug Stendra in the U.S. and Canada as part of a deal between the two companies that could be worth more than $300 million.

Tags: deal drug licenses 300m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »